Loading…
Arcutis Biotherapeutics, Inc. is projected to rise to $33.93 by 2027, a +22% move from its current price of $27.74. ARQT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $27.10 | $27.76 | $28.43 | +0.07% |
| Jul 13 | $26.86 | $27.78 | $28.74 | +0.15% |
| Jul 14 | $26.67 | $27.80 | $28.98 | +0.22% |
| Jul 15 | $26.52 | $27.82 | $29.18 | +0.29% |
| Jul 16 | $26.39 | $27.84 | $29.37 | +0.37% |
| Jul 17 | $26.28 | $27.86 | $29.54 | +0.44% |
| Jul 18 | $26.17 | $27.88 | $29.70 | +0.51% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.17 | $27.88 | $29.70 | +0.51% |
| Week 2 | $25.62 | $28.02 | $30.65 | +1.03% |
| Week 3 | $25.24 | $28.17 | $31.43 | +1.54% |
| Week 4 | $24.95 | $28.31 | $32.13 | +2.06% |
| Week 5 | $24.70 | $28.46 | $32.78 | +2.59% |
| Week 6 | $24.49 | $28.60 | $33.40 | +3.11% |
| Week 7 | $24.32 | $28.75 | $33.99 | +3.64% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Arcutis Biotherapeutics, Inc. is a biopharmaceutical company that develops and commercializes treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis.
The company also develops ZORYVE foam for seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc.
in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
ARQT is the stock ticker for Arcutis Biotherapeutics, Inc. and is currently trading at $28.78. The company has a market capitalization of $3.6B and is ranked 1630 by market capitalization.
The price outlook is presented through a year-by-year forecast that shows a neutral outlook for 2026 and bullish outlooks for subsequent years. The forecast projects an upward trajectory with the average price rising to $57.26 by 2030, $181.36 by 2040, and $381.70 by 2050, illustrating substantial long‑term upside.
A major floor 35.9% below — a decisive break under it would weaken the trend.
The nearest floor, 25.1% below — buyers have tended to step in here.
The nearest ceiling, 3.7% above — a clean break opens room to run.
A major ceiling 21.7% above — clearing it would confirm fresh momentum.
Key ARQT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARQT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.75 | Sell | $27.76 | Sell |
| MA 10 | $27.04 | Buy | $27.22 | Buy |
| MA 20 | $26.50 | Buy | $26.25 | Buy |
| MA 50 | $23.60 | Buy | $24.75 | Buy |
| MA 100 | $23.85 | Buy | $24.26 | Buy |
| MA 200 | $24.68 | Buy | $23.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.39 | Neutral |
| Stoch RSI (14) | 32.63 | Neutral |
| CCI (20) | 95.38 | Neutral |
| Williams %R (14) | -35.02 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 5.60 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 64.98 | Neutral |
| TRIX (15) | 0.74 | Buy |
| Awesome (5,34) | 3.30 | Buy |
| Ultimate (7,14,28) | 65.30 | Neutral |
| Momentum (10) | 1.05 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 28.85 | Sell |
| ADX (14) | 28.79 | Buy |
| ATR (14) | 0.58 | Info |
The 30-day technical picture is bullish, with RSI14 at 70. The 50-day simple moving average is $23.51 and the 200-day simple moving average is $24.63. Immediate support is at $20.79 and resistance at $28.78. The 30-day range is $24.68 to $33.56, reflecting near-term price exploration within those bounds and a constructive setup for a continued move.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.50 | $27.74 | $38.88 | 0% | Neutral | |
| $27.32 | $33.93 | $44.38 | +22% | Bullish | |
| $32.35 | $41.15 | $55.63 | +48% | Bullish | |
| $37.32 | $48.44 | $67.20 | +75% | Bullish | |
| $43.26 | $57.13 | $81.01 | +106% | Bullish | |
| $54.98 | $73.78 | $106.64 | +166% | Bullish | |
| $60.18 | $81.96 | $120.50 | +195% | Bullish | |
| $64.65 | $89.28 | $133.33 | +222% | Bullish | |
| $72.21 | $101.03 | $153.07 | +264% | Bullish | |
| $71.55 | $101.37 | $155.64 | +265% | Bullish | |
| $124.94 | $187.32 | $304.19 | +575% | Bullish | |
| $243.25 | $401.35 | $707.68 | +13.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.50 | $27.74 | $34.16 | +0.00% |
| August 2026 | $25.08 | $29.50 | $35.58 | +6.36% |
| September 2026 | $25.05 | $29.65 | $36.10 | +0.49% |
| October 2026 | $25.70 | $30.58 | $37.55 | +3.15% |
| November 2026 | $26.38 | $31.53 | $38.97 | +3.09% |
| December 2026 | $26.04 | $31.25 | $38.88 | -0.87% |
Click any year to see its month-by-month ARQT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ARQT to range from $19.50 to $38.88 through 2026. The $27.74 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ARQT price prediction for 2027 points to an average of $33.93 (low $27.32, high $44.38) — a potential gain of +22% on today's $27.74. Momentum favours further upside here.
In 2028, ARQT is projected to trade between $32.35 and $55.63, averaging $41.15 — a potential gain of +48% from today's $27.74. That is up +21% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Arcutis Biotherapeutics, Inc.'s 2029 outlook centres on $48.44, within a $37.32 to $67.20 range. That is up +18% on the projected 2028 average. That marks a +75% change versus current levels. Momentum favours further upside here.
By 2030, ARQT could reach as high as $81.01, with a base case around $57.13 and support toward $43.26 — roughly +106% from $27.74. Buyers look set to stay in control over this stretch.
Expect ARQT to range from $54.98 to $106.64 through 2031. The $73.78 average target implies a +166% move from current prices. That is up +29% on the projected 2030 average. Momentum favours further upside here.
The ARQT price prediction for 2032 points to an average of $81.96 (low $60.18, high $120.50) — a potential gain of +195% on today's $27.74. Buyers look set to stay in control over this stretch.
In 2033, ARQT is projected to trade between $64.65 and $133.33, averaging $89.28 — a potential gain of +222% from today's $27.74. That is up +9% on the projected 2032 average. Momentum favours further upside here.
Arcutis Biotherapeutics, Inc.'s 2034 outlook centres on $101.03, within a $72.21 to $153.07 range. That is up +13% on the projected 2033 average. That marks a +264% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ARQT could reach as high as $155.64, with a base case around $101.37 and support toward $71.55 — roughly +265% from $27.74. Momentum favours further upside here.
Expect ARQT to range from $124.94 to $304.19 through 2040. The $187.32 average target implies a +575% move from current prices. That is up +85% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ARQT price prediction for 2050 points to an average of $401.35 (low $243.25, high $707.68) — a potential gain of +13.5x on today's $27.74. Momentum favours further upside here.
Investing $1,000 in ARQT today (≈ 36.049027 ARQT) could be worth
$14,468.27
+$13,468.27 (+1347%) by 2050 · US Dollar
Based on the average projected ARQT price of $401.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARQTwould be worth at today's price.
$1,000 invested in ARQT on Jul 10, 2025 (≈ 65.487883 ARQT) would be worth
$1,816.63
+$816.63 (+81.7%) today · 1.82× · US Dollar
Based on a ARQT entry price of $15.27 vs. today's $27.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.81 | $1,074.78 | +7.5% |
| 1 month ago | $23.23 | $1,194.15 | +19.4% |
| 3 months ago | $24.21 | $1,145.81 | +14.6% |
| 6 months ago | $26.78 | $1,035.85 | +3.6% |
| 1 year ago | $15.27 | $1,816.63 | +81.7% |
| All time (5.0y) ago | $27.06 | $1,025.13 | +2.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARQT forecast.
Our base-case forecast reaches $55.00 around 2030.
Implied market cap at $55.00: $6.88B
The multi-year forecast points to a strong long‑run upside. By 2030, the average forecast price is $57.26 with a max of $80.81 and a min of $43.52, and the ROI is projected at 99. By 2040, the average forecast price is $181.36 with a max of $292.34 and a min of $121.92, with a ROI of 530.1.
By 2050, the average forecast price is $381.70 with a max of $667.07 and a min of $233.95, with a ROI of 1226.3. The outlook remains bullish across these horizon years, supported by higher average prices in the later years, though 2026 is described as Neutral. These figures are estimates and not guaranteed, and actual results may differ due to market and company-specific factors.
Tap a question to reveal the answer.
Avg $57.26; min $43.52; max $80.81; ROI 99; sentiment BULLISH.
The forecast shows a bullish long-term path with average prices rising to $381.70 by 2050, but these are estimates, not guarantees, and involve risk.
Yes. The forecast max exceeds $100 in several years, including 2031 (max $105.60) and continuing higher in later years (2032 max $118.89; 2033 max $131.19; 2034 max $149.84; 2035 max $152.04; 2040 max $292.34; 2050 max $667.07).
Current price is $28.78. Market cap is $3.6B. Rank 1630.
RSI14 is 70 with sentiment BULLISH. The SMA50 is $23.51 and the SMA200 is $24.63. Support is at $20.79 and resistance at $28.78. The 30-day range is $24.68 to $33.56.
Arcutis Biotherapeutics, Inc. Community Discussion
0Share your Arcutis Biotherapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.